Scottish Mortgage Investment Trust (LSE: SMT) shares have found their groove again in recent months. They’re now up around 30% in 12 months. And in 2024 alone, they’ve advanced 10% to 890p (that’s better than the FTSE 100 year to date).
Clearly, Nvidia‘s staggering performance has helped, as has strong share price gains for Temu owner PDD Holdings over the last year.
Meta Platforms stock has also done well since it was reintroduced into the portfolio a few months ago.
This is encouraging because these are large Scottish Mortgage holdings. The picture isn’t as pretty down the bottom of the portfolio, but that shouldn’t be a big negative long term. It’s the top end that really matters.
Here, I’ll consider one major holding that has also been surging higher recently. Given its heavy weighting, it could boost further returns for the trust if progress continues.
Bird flu outbreak
I’m talking about messenger RNA (mRNA) vaccine pioneer Moderna (NASDAQ: MRNA). The stock has been on a tear, doubling in value since November.
This is partly down to an outbreak of bird flu spreading among dairy cows. Moderna shares have risen 35% since 1 April, when the second known human case in the US was reported.
A third person recently tested positive after having contact with cattle carrying the H5N1 virus. And while no human-to-human transmission has been reported yet, the US government isn’t taking any chances.
Reports say federal funding could be heading the way of Moderna and vaccine rival Pfizer to test experimental shots against several strains of the virus (including the circulating one).
On 30 May, Moderna told Reuters that it had already completed dosing in an early-to-mid stage study of the vaccine, and it expects data from this soon.
A software firm in disguise
In a nutshell, we have here the reason why Scottish Mortgage managers believe Moderna could become a transformational growth company.
The speed at which its mRNA platform can tweak code to summon up effective vaccine candidates on demand is astonishing. This is why I’m invested in this stealthy software company.
Just as Nvidia’s GPUs have uses beyond computer graphics, mRNA technology offers a wide range of applications outside of Covid vaccines.
Already, we’re seeing very encouraging data from trials of a personalised mRNA skin cancer vaccine that activates the body’s immune system to identify cancerous cells and remove them.
There’s the potential this could work in indications outside melanoma, with trials for non-small cell lung cancer vaccines ongoing.
Above £10?
Naturally, there are risks with Moderna, as there are with Scottish Mortgage shares. One is a return of inflation, which could keep interest rates higher for longer and heap pressure on both share prices.
Plus, Moderna’s at the mercy of clinical trials, which can always go wrong at any stage. It has over 40 drugs in development, including a vaccine for AIDS. Crucially though, it has the wherewithal ($13.3bn at year-end) to fund these programmes.
On 31 May, the company had its second mRNA product approved for respiratory syncytial virus (RSV). It expects to return to sales growth in 2025 following a massive post-Covid drop-off in demand.
If more progress follows in the coming months, I expect excitement to build and potentially push Scottish Mortgage shares above £10.
The post 1 intriguing growth stock that could send Scottish Mortgage shares above £10 appeared first on The Motley Fool UK.
5 Shares for the Future of Energy
Investors who don’t own energy shares need to see this now.
Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.
While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.
Open this new report — 5 Shares for the Future of Energy — and discover:
Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
How to potentially get paid by the weather
Electric Vehicles’ secret backdoor opportunity
One dead simple stock for the new nuclear boom
Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!
Grab your FREE Energy recommendation now
More reading
£50k in savings? Here’s how I’d aim for a second income worth £60,000 a year
I’m up 25%! The Nvidia share price and other giants power this UK investment trust
I bought Fundsmith Equity and Scottish Mortgage shares last year. Now I’m selling one of them
Scottish Mortgage shares rise following FY update! Time to buy?
Up 25% in six months, where next for Scottish Mortgage shares?
Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool’s board of directors. Ben McPoland has positions in Moderna and Scottish Mortgage Investment Trust Plc. The Motley Fool UK has recommended Meta Platforms and Nvidia. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.